US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 5.720
  • +0.030+0.53%
Trading May 15 12:25 ET
95.67MMarket Cap-5.35P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-40.79%3.55M
-99.97%1.95K
0
3.43M
126.84K
6M
6M
0
0
0
Operating revenue
-40.79%3.55M
-99.97%1.95K
--0
--3.43M
--126.84K
--6M
--6M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.61%20.8M
-2.50%4.08M
24.87%4.45M
104.69%6.66M
93.44%5.61M
41.72%13.91M
108.98%4.19M
33.89%3.56M
-5.57%3.25M
70.56%2.9M
Selling and administrative expenses
13.43%8.89M
-10.07%2.14M
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
-General and administrative expense
13.43%8.89M
-10.07%2.14M
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
Research and development costs
96.71%11.89M
7.47%1.94M
39.67%2.22M
222.02%4.57M
156.81%3.16M
22.42%6.04M
64.19%1.8M
12.66%1.59M
-2.03%1.42M
25.84%1.23M
Depreciation amortization depletion
0.00%27.36K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
-Depreciation and amortization
0.00%27.36K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
Operating profit
-118.26%-17.25M
-324.79%-4.08M
-24.87%-4.45M
0.56%-3.24M
-89.06%-5.48M
19.45%-7.9M
190.60%1.82M
-33.89%-3.56M
5.57%-3.25M
-70.56%-2.9M
Net non-operating interest income expense
Other net income (expense)
157.86%1.65M
154.32%444.23K
201.83%428.87K
116.67%344.45K
163.45%431.09K
126.28%639.37K
115.82%174.67K
110.46%142.09K
377.60%158.97K
5,523.73%163.63K
Other non- operating income (expenses)
157.86%1.65M
154.32%444.23K
201.83%428.87K
116.67%344.45K
163.45%431.09K
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
Income before tax
-114.77%-15.6M
-282.73%-3.64M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Income tax
-199.51%-720.29K
723.85K
Net income
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Net income continuous Operations
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Minority interest income
Net income attributable to the parent company
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Basic earnings per share
-24.05%-0.98
-220.00%-0.18
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
Diluted earnings per share
-24.05%-0.98
-220.00%-0.18
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -40.79%3.55M-99.97%1.95K03.43M126.84K6M6M000
Operating revenue -40.79%3.55M-99.97%1.95K--0--3.43M--126.84K--6M--6M--0--0--0
Cost of revenue
Gross profit
Operating expense 49.61%20.8M-2.50%4.08M24.87%4.45M104.69%6.66M93.44%5.61M41.72%13.91M108.98%4.19M33.89%3.56M-5.57%3.25M70.56%2.9M
Selling and administrative expenses 13.43%8.89M-10.07%2.14M12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M
-General and administrative expense 13.43%8.89M-10.07%2.14M12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M
Research and development costs 96.71%11.89M7.47%1.94M39.67%2.22M222.02%4.57M156.81%3.16M22.42%6.04M64.19%1.8M12.66%1.59M-2.03%1.42M25.84%1.23M
Depreciation amortization depletion 0.00%27.36K0.00%6.84K0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K
-Depreciation and amortization 0.00%27.36K0.00%6.84K0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K
Operating profit -118.26%-17.25M-324.79%-4.08M-24.87%-4.45M0.56%-3.24M-89.06%-5.48M19.45%-7.9M190.60%1.82M-33.89%-3.56M5.57%-3.25M-70.56%-2.9M
Net non-operating interest income expense
Other net income (expense) 157.86%1.65M154.32%444.23K201.83%428.87K116.67%344.45K163.45%431.09K126.28%639.37K115.82%174.67K110.46%142.09K377.60%158.97K5,523.73%163.63K
Other non- operating income (expenses) 157.86%1.65M154.32%444.23K201.83%428.87K116.67%344.45K163.45%431.09K904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K
Income before tax -114.77%-15.6M-282.73%-3.64M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Income tax -199.51%-720.29K723.85K
Net income -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Net income continuous Operations -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Minority interest income
Net income attributable to the parent company -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Basic earnings per share -24.05%-0.98-220.00%-0.1823.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28
Diluted earnings per share -24.05%-0.98-220.00%-0.1823.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
BAWEI
837023
+29.97%
XI'AN WONDER
836419
+28.12%
Jiangsu Tiangong Technology
920068
+20.29%
4
Fujian Green Pine
300132
+20.08%
5
Yili Chuanning Biotechnology
301301
+20.03%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025